H69 CDX Model

The H69 cell line is derived from human small cell lung cancer (SCLC), a highly aggressive and rapid-growing subtype of lung cancer with a propensity for early metastasis. H69 provides a pivotal model for deciphering the intricate biology of SCLC and for appraising potential therapeutic strategies. This cell line embodies many molecular features and genetic alterations characteristic of SCLC, establishing its relevance for preclinical studies focused on tumor development, progression, and treatment. The in vitro and in vivo behaviors of H69 render insights into the aggressive growth kinetics of SCLC, its neuroendocrine features, metastatic potential, and responses to chemotherapeutic agents. Researchers extensively employ the H69 model to understand the molecular mechanisms driving SCLC and to develop and assess therapeutic strategies, especially those aimed at addressing chemoresistance and preventing metastatic spread.

Request Additional CDX Model Data


Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our expert staff today to get started.